Advertisement

The Enzymic Defects in Morquio and Maroteaux-Lamy Syndrome

  • Albert Dorfman
  • Bradley Arbogast
  • Reuben Matalon
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 68)

Abstract

The mucopolysaccharidoses are a group of heritable diseases which result from defective degradation of glycosaminoglycans. Since the original descriptions of Hunter and Hurler (15,16), there has been an extensive clinical and biochemical literature. The earlier studies have been reviewed elsewhere (10, 25, 33). Studies during the last few years have elucidated the enzyme defects in Hurler, Scheie, Hunter and Sanfilippo A and B diseases (9,26). More recently, several reports have appeared concerned with defects in Maroteaux-Lamy and Morquio diseases (2,4,12,13,23,24,27,31). These two syndromes are distinguished from the other mucopolysaccharidoses by lack of mental retardation in the presence of severe somatic changes. Maroteaux {ulet al}. (22) described a group of patients with marked somatic defects and no mental retardation except that which occurs secondary to the frequent hydrocephalus. In contrast to the excretion of heparan sulfate and dermatan sulfate in Hurler disease, patients with Maroteaux-Lamy disease excrete only dermatan sulfate. Morquio disease is manifested by spondoepiphyseal dysplasia and corneal clouding.

Keywords

Heparan Sulfate Chondroitin Sulfate Dermatan Sulfate Keratan Sulfate ENZYMIC Defect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arbogast, B., Hopwood, J. J. and Dorfman, A. Absence of Hyaluronidase in Cultured Human Skin Fibroblasts. Biochem. Biophys. Res. Commun., in press (1975).Google Scholar
  2. 2.
    Austin, J. H. Studies in Metachromatic Leukodystrophy. XII. Multiple Sulfatase Deficiency. Archiv. Neurol. 28, 258 (1973).CrossRefGoogle Scholar
  3. 3.
    Beaudet, A. L., Di Ferrante, N. M., Ferry, G. D., Nichols, B. L. and Mullins, C. E. Variation in Phenotypic Expression of α-Glucuronidase Deficiency. J. Peds. 86, 388 (1975).CrossRefGoogle Scholar
  4. 4.
    Beratis, N. G., Turner, B. M., Weiss, R. and Hirschhorn, K. Arylsulfatase B Deficiency in Maroteaux-Lamy Syndrome. Cellular Studies and Carrier Identification. Ped. Res. 9, 475 (1975).CrossRefGoogle Scholar
  5. 5.
    Cantz, M. and Kresse, H. Sandhoff Disease: Defective Glycosaminoglycan Catabolism in Cultured Fibroblasts and Its Correction by β-N-Acetylhexosaminidase. Europ. J. Biochem. 47, 581 (1974).PubMedCrossRefGoogle Scholar
  6. 6.
    Cashman, D. S., Laryeu, J. U. and Weissmann, B. The Hyaluronidase of Rat Skin. Archiv. Biochem. Biophys. 135, 387 (1969).CrossRefGoogle Scholar
  7. 7.
    Choi, H. U., Meyer, K. and Swarm, R. Mucopolysaccharide and Protein-Polysaccharide of a Transplantable Rat Chondrosarcoma. Proc. Natl. Acad. Sci. USA 613, 877 (1971).CrossRefGoogle Scholar
  8. 8.
    Cifonelli, J. A. and King, J. The Distribution of Sulfated Uronic Acid and Hexosamine Residues in Heparin and Heparan Sulfate. Conn. Tiss. Res. 3 97 (1975).CrossRefGoogle Scholar
  9. 9.
    Dorfman, A. and Matalon, R. The Mucopolysaccharidoses. Proc. Natl. Acad. Sci. USA, in press (1975).Google Scholar
  10. 10.
    Dorfman, A. and Matalon, R. In: “The Metabolic Basis of Inherited Diseases”. Eds: Stanbury, J. B., Wyngaarden, J. B. and Fredrickson, D. S. New York, McGraw Hill, Third Edition, 1972, p. 1218.Google Scholar
  11. 11.
    Eto, Y., Wiesmann, U. N., Carlson, J. H., Herskovitz, N. N. Multiple Sulfatase Deficiencies in Cultured Fibroblasts. Archiv. Neurol. 30, 153 (1974).CrossRefGoogle Scholar
  12. 12.
    Fluharty, A. L., Stevens, R. L., Fung, D., Peak, S. and Kihara, H. Uridine Diphospho-N-Acetylgalactosamine-4-Sulfate Sulfohydrolase Activity of Human Arylsulfatase B and its Deficiency in the Maroteaux-Lamy Syndrome. Biochem. Biophys. Res. Commun. 64, 955 (1975).PubMedCrossRefGoogle Scholar
  13. 13.
    Fluharty, A. L., Stevens, R. L., Sanders, D. L. and Kihara, H. Arylsulfatase B Deficiency in Maroteaux-Lamy Syndrome in Cultured Fibroblasts. Biochem. Biophys. Res. Commun. 59, 455 (1974).PubMedCrossRefGoogle Scholar
  14. 14.
    Gehler, J., Cantz, M., Tolksdorf, M. and Spranger, J. Mucopolysaccharidosis. VII. β-Glucuronidase Deficiency. Humangenetik 23, 149 (1974).PubMedGoogle Scholar
  15. 15.
    Hunter, C. A Rare Disease in Two Brothers. Proc. Roy. Soc. Med. 10, 104 (1917).PubMedGoogle Scholar
  16. 16.
    Hurler, G. Uber Eninen Typ Multipler Abartungen, Vorwiegend am Skelettsystem. Z. Kinderheilk. 24, 220 (1919).CrossRefGoogle Scholar
  17. 17.
    Hutterer, F. Degradation of Mucopolysaccharides by Hepatic Lysosomes. Biochim. Biophys. Acta 115, 312 (1966).PubMedCrossRefGoogle Scholar
  18. 18.
    Kaplan, D. Classification of the Mucopolysaccharidoses Based on the Pattern of Mucopolysacchariduria. Am. J. Med. 47, 721 (1969).PubMedCrossRefGoogle Scholar
  19. 19.
    Kaplan, D., McKusick, V. A., Trebach, S. and Lazarus, R. Keratosulfate in Chondroitin Sulfate Peptide from Normal Urines and from Urine of Patients with Morquio Syndrome (Mucopolysaccharidosis IV). J. Lab. Clin. Med. 71, 48 (1968).PubMedGoogle Scholar
  20. 20.
    Knecht, J., Cifonelli, J. A. and Dorfman, A. Structural Studies on Heparitin Sulfate of Normal and Hurler Tissues. J. Biol. Chem. 242, 4652 (1967).PubMedGoogle Scholar
  21. 21.
    Kresse, H. and von Figura, K. A New Biochemical Subtype of the Sanfilippo Syndrome: Sanfilippo C Disease. Third International Symposium of Glycoconjugates, Brighton, England (1975) (Abst.).Google Scholar
  22. 22.
    Maroteaux, B., Leveque, B., Marie, J. and Lamy, M. Une Nouvelle Dysostose Avec Elimination Urinaire de Chonddroitine Sulfate B. Presse Med. 71, 1849 (1963).PubMedGoogle Scholar
  23. 23.
    Matalon, R., Arbogast, B. and Dorfman, A. Deficiency of Chondroitin Sulfate N-Acetylgalactosamine 4-Sulfate Sulfatase in Maroteaux-Lamy Syndrome. Biochem. Biophys. Res. Commun. 61, 1450 (1974).PubMedCrossRefGoogle Scholar
  24. 24.
    Matalon, R., Arbogast, B., Justice, P., Brandt, I. K. and Dorfman, A. Morquio’s Syndrome: Deficiency of a Chondroitin Sulfate N-Acetylhexosamine Sulfate Sulfatase. Biochem. Biophys. Res. Commun. 61, 759 (1974).PubMedCrossRefGoogle Scholar
  25. 25.
    McKusick, V. A. Heritable Disorders of Connective Tissue. St. Louis, C. V. Mosby, 4th Edition, 1972.Google Scholar
  26. 26.
    Neufeld, E. F., Lim, T. W. and Shapiro, L. J. Inherited Disorders of Lysosomal Metabolism. In: “Annual Review of Biochemistry”. Eds: Snell, E. E., Boyer, P. D., Meister, A. and Richardson, C. C. Palo Alto, Annual Reviews, 1975, Volume 44, p. 357.Google Scholar
  27. 27.
    O’Brien, J. F., Cantz, M. and Spranger, J. Maroteaux-Lamy Disease (Mucopolysaccharidosis VI), Subtype A: Deficiency of a N-Acetylgalactosamine-4-Sulfatase. Biochem. Biophys. Res. Commun. 60, 1170 (1974).PubMedCrossRefGoogle Scholar
  28. 28.
    Ogren, S. and Lindahl, U. Cleavage of Macromolecular Heparan by an Enzyme from Mouse Mastocytoma. J. Biol. Chem. 250, 2690 (1975).PubMedGoogle Scholar
  29. 29.
    Pedrini, V., Lenzi, L. and Zambotti, V. Isolation and Identification of Keratosulfate in Urine of Patients Affected by Morquio-Ullrich Disease. Proc. Soc. Exp. Biol. Med. 110 847 (1962).PubMedGoogle Scholar
  30. 30.
    Pedrini-Mille, A., Pedrini, V. A. and Ponseti, I. V. Glycosaminoglycans of Iliac Crest Cartilage in Normal Children and in Morquio’s Disease. J. Lab. Clin. Med. 84, 465 (1974).PubMedGoogle Scholar
  31. 31.
    Shapira, E., DeGregorio, R. R., Matalon, R. and Nadler, H. L. Reduced Arylsulfatase B Activity of the Mutant Enzyme Protein in Maroteaux-Lamy Syndrome. Biochem. Biophys. Res. Commun. 62, 448 (1975).PubMedCrossRefGoogle Scholar
  32. 32.
    Sly, W. S., Quinton, B. S., McAlister, W. H. and Rimoin, D. L. Beta-Glucuronidase Deficiency: Report of Clinical, Radiologic and Biochemical Features of a New Mucopolysaccharidosis. J. Pediat. 82, 249 (1973).PubMedCrossRefGoogle Scholar
  33. 33.
    Spranger, J. The Systemic Mucopolysaccharidoses. Ergeb der Inn. Med. Kinderhl. 32, 166 (1972).Google Scholar
  34. 34.
    Tanaka, H. and Suzuki, K. Lactosylceramide β-Galactosidase in Human Sphingolipidoses. Evidence of Two Genetically Distinct Enzymes. J. Biol. Chem. 250, 2324 (1975).PubMedGoogle Scholar
  35. 35.
    Thompson, J. N., Stoolmiller, A. C., Matalon, R. and Dorfman, A. N-Acetyl-β-Hexosaminidase: Role in the Degradation of Glycosaminoglycans. Science 181, 866 (1973).CrossRefGoogle Scholar
  36. 36.
    Tsay, G. C. and Dawson, G. Structure of the “Keratosulfate-Like” Material from a Patient with GM1-Gangliosidosis (β-D-Galactosidase Deficiency). Biochem. Biophys. Res. Commun. 52, 759 (1973).PubMedCrossRefGoogle Scholar
  37. 37.
    Tudball, N. and Davidson, E. A. Isolation of a Novel Sulphatase from Rat Liver. Biochim. Biophys. Acta 171, 113 (1968).Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Albert Dorfman
    • 1
  • Bradley Arbogast
    • 1
  • Reuben Matalon
    • 1
  1. 1.Departments of Pediatrics and Biochemistry, and the Joseph P. Kennedy, Jr., Mental Retardation Research CenterPritzker School of Medicine, University of ChicagoChicagoUSA

Personalised recommendations